AF
CMPX icon

Allworth Financial’s Compass Therapeutics CMPX Stock Holding History

Allworth Financial’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1K Buy
10,084
+9,492
+1,603% +$28K ﹤0.01% 3109
2026
Q1 		$3.13K Buy
592
+572
+2,860% +$3.3K ﹤0.01% 4192
2025
Q4 		$108 Buy
20
+16
+400% +$74 ﹤0.01% 4775
2025
Q3 		$14 Buy
+4
New +$13 ﹤0.01% 4846

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Allworth Financial's CMPX Position: Q2 2026 in Review

Allworth Financial increased its Compass Therapeutics (CMPX) stake by 1,603% in Q2 2026, buying an estimated $28K and bringing the position to 10,084 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3109.

Allworth Financial first reported a position in CMPX in Q3 2025 and has held it in 4 quarters since. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Allworth Financial held 10,084 shares of Compass Therapeutics worth $22.1K as of Q2 2026.
  • Allworth Financial bought 9,492 Compass Therapeutics shares in Q2 2026, an estimated $28K.
  • Compass Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3109 holding.
  • Allworth Financial first reported a position in Compass Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.